Loading
HKSEHealthcareMedical - Care Facilities
Latest quote
HK$0.435
+HK$0.025 · +6.10%
EC Healthcare, an investment holding firm, delivers an extensive range of medical and healthcare services throughout Hong Kong, Macau, and mainland China. Its operations are structured into three primary divisions: Medical, Aesthetic Medical and Beauty and Wellness, and an 'Others' category. The company's diverse service offerings include quasi-medical treatments, beauty and wellness programs, medical imaging, surgical procedures, aesthetic medicine, dentistry, hair restoration, vaccinations, chiropractic care, psychological support, and orthopedic services. Beyond direct patient care, EC Healthcare also provides administrative and management support, laboratory diagnostics, various marketing and performance marketing solutions, and even travel agency services. Furthermore, it retails beauty and skincare products, manages healthcare machinery, engages in property investment, offers multi-channel networking, and extends its expertise to veterinary services. Its product and service portfolio is primarily marketed under proprietary brands such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. Established in 2005 and headquartered in Mong Kok, Hong Kong, the company was formerly known as Union Medical Healthcare Limited before rebranding to EC Healthcare in April 2021.
Latest quote
HK$0.435
+HK$0.025 · +6.10%
Regular session · HKT · Market data may be delayed.
EC Healthcare, an investment holding firm, delivers an extensive range of medical and healthcare services throughout Hong Kong, Macau, and mainland China. Its operations are structured into three primary divisions: Medical, Aesthetic Medical and Beauty and Wellness, and an 'Others' category. The company's diverse service offerings include quasi-medical treatments, beauty and wellness programs, medical imaging, surgical procedures, aesthetic medicine, dentistry, hair restoration, vaccinations, chiropractic care, psychological support, and orthopedic services. Beyond direct patient care, EC Healthcare also provides administrative and management support, laboratory diagnostics, various marketing and performance marketing solutions, and even travel agency services. Furthermore, it retails beauty and skincare products, manages healthcare machinery, engages in property investment, offers multi-channel networking, and extends its expertise to veterinary services. Its product and service portfolio is primarily marketed under proprietary brands such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. Established in 2005 and headquartered in Mong Kok, Hong Kong, the company was formerly known as Union Medical Healthcare Limited before rebranding to EC Healthcare in April 2021.
Day range
Current HK$0.435
52-week range
Current HK$0.435
Regular session · HKT · Market data may be delayed.
EC Healthcare, an investment holding firm, delivers an extensive range of medical and healthcare services throughout Hong Kong, Macau, and mainland China. Its operations are structured into three primary divisions: Medical, Aesthetic Medical and Beauty and Wellness, and an 'Others' category. The company's diverse service offerings include quasi-medical treatments, beauty and wellness programs, medical imaging, surgical procedures, aesthetic medicine, dentistry, hair restoration, vaccinations, chiropractic care, psychological support, and orthopedic services. Beyond direct patient care, EC Healthcare also provides administrative and management support, laboratory diagnostics, various marketing and performance marketing solutions, and even travel agency services. Furthermore, it retails beauty and skincare products, manages healthcare machinery, engages in property investment, offers multi-channel networking, and extends its expertise to veterinary services. Its product and service portfolio is primarily marketed under proprietary brands such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. Established in 2005 and headquartered in Mong Kok, Hong Kong, the company was formerly known as Union Medical Healthcare Limited before rebranding to EC Healthcare in April 2021.
Day range
Current HK$0.435
52-week range
Current HK$0.435
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (HKD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.77B HKD | 4.14B HKD | 4.21B HKD | 3.88B HKD | 2.92B HKD |
| Cost of goods sold | 3.17B HKD | 797.95M HKD | 666.13M HKD | 552.95M HKD | 349.6M HKD |
| Gross profit | 600.33M HKD | 3.34B HKD | 3.54B HKD | 3.32B HKD | 2.57B HKD |
| Selling, general, and administrative | — | 432.37M HKD | 426.37M HKD | 405.36M HKD | 302.02M HKD |
| Operating expenses | 565.75M HKD | 3.25B HKD | 3.36B HKD | 3.08B HKD | 2.18B HKD |
| Interest income | 16.02M HKD | 17.4M HKD | 15.57M HKD | 4.53M HKD | 1.36M HKD |
| Interest expense | 71.67M HKD | 89.44M HKD | 100.84M HKD | 63.64M HKD | 48.91M HKD |
| Depreciation and amortization | 512.24M HKD | 630.98M HKD | 625.55M HKD | 586.74M HKD | 432.37M HKD |
| Operating income | 34.59M HKD | 94.94M HKD | 109.04M HKD | 218.94M HKD | 363.07M HKD |
| Net income | −402.72M HKD | −167.19M HKD | −18.95M HKD | 69.65M HKD | 197.5M HKD |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis International Equity ETFAVDE
Avantis Responsible International Equity ETFAVSD
Avantis International Small Cap Equity ETFAVDSAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
